Terms: = Bone cancer AND SMARCB1, Ini1, 6598, ENSG00000099956, Snr1, SNF5L1, RDT, BAF47, hSNFS, SNF5, INI1, Sfh1p, Q12824
137 results:
1. The role of systemic therapy in advanced skull base chordomas: overview of the current state and the MD Anderson protocol.
Banu MA; Raza SM; Amini M; Seaman S; Rubino F; Snyder R; Patel S; DeMonte F; Conley AP
Neurosurg Focus; 2024 May; 56(5):E15. PubMed ID: 38691867
[TBL] [Abstract] [Full Text] [Related]
2. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
3. smarcb1-Deficient Skull Base Chondrosarcoma with 12p Duplication Presenting as Somatic-Type Malignancy Arising from Metastatic Seminoma.
Argyris PP; Challa B; Satturwar S; VanKoevering KK; Wakely PE
Head Neck Pathol; 2024 Jan; 18(1):1. PubMed ID: 38236556
[TBL] [Abstract] [Full Text] [Related]
4. The medial transorbital approach in cranioendoscopic skull base tumor resections for locally advanced tumors.
Scholfield DW; Levyn H; Tabar VS; Ganly I; Della Rocca D; Cohen MA
J Clin Neurosci; 2024 Jan; 119():198-204. PubMed ID: 38134571
[TBL] [Abstract] [Full Text] [Related]
5. smarcb1 (ini1)-deficient sinonasal carcinoma manifesting as oral lesions: A report of two cases.
Fuoco J; Huang M; Esfandiari N; MacMillan C; Ali A; Dave K; Freilich M; Magalhaes M
Head Neck; 2024 Mar; 46(3):E32-E39. PubMed ID: 38088461
[TBL] [Abstract] [Full Text] [Related]
6. Diagnostic algorithm for challenging blue cell sinonasal carcinoma.
Laforga JB; Abdullah B
Pathol Res Pract; 2023 Aug; 248():154683. PubMed ID: 37478521
[TBL] [Abstract] [Full Text] [Related]
7. CRISPR-Cas9 screening identified lethal genes enriched in necroptosis pathway and of prognosis significance in osteosarcoma.
Cheng L; Xiong W; Li S; Wang G; Zhou J; Li H
J Gene Med; 2023 Dec; 25(12):e3563. PubMed ID: 37421290
[TBL] [Abstract] [Full Text] [Related]
8. Transcriptomic and immunophenotypic characterization of two cases of adamantinoma-like Ewing sarcoma of the thyroid gland.
Chatzopoulos K; Davila JI; Fadra N; Jackson RA; Minn KT; Sotiriou S; Oliveira AM; Erickson LA; Halling KC; Rumilla KM; Rivera M
Histopathology; 2023 Sep; 83(3):426-434. PubMed ID: 37195579
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological features of five cases of CIC::DUX4 positive sarcomas, including literature review.
Rekhi B; Rumdee R; Shetty O
Ann Diagn Pathol; 2023 Aug; 65():152153. PubMed ID: 37167753
[TBL] [Abstract] [Full Text] [Related]
10. Ovarian epithelioid malignant peripheral nerve sheath tumor with EWSR1-CREM fusion: A case report and literature review.
Li S; Hong R; Wang X; Yang J
Int J Gynaecol Obstet; 2023 Nov; 163(2):521-527. PubMed ID: 37151162
[TBL] [Abstract] [Full Text] [Related]
11. SWI/SNF-deficient Sinonasal Carcinomas.
Agaimy A
Adv Anat Pathol; 2023 Mar; 30(2):95-103. PubMed ID: 36580412
[TBL] [Abstract] [Full Text] [Related]
12. The genetic landscape of smarcb1 alterations in smarcb1-deficient spectrum of mesenchymal neoplasms.
Dermawan JK; Singer S; Tap WD; Nacev BA; Chi P; Wexler LH; Ortiz MV; Gounder M; Antonescu CR
Mod Pathol; 2022 Dec; 35(12):1900-1909. PubMed ID: 36088476
[TBL] [Abstract] [Full Text] [Related]
13. Stimulated Raman Histology for Rapid Intra-Operative Diagnosis of Sinonasal and Skull Base Tumors.
Fitzgerald CWR; Dogan S; Bou-Nassif R; Mclean T; Woods R; Cracchiolo JR; Ganly I; Tabar V; Cohen MA
Laryngoscope; 2022 Nov; 132(11):2142-2147. PubMed ID: 35634892
[TBL] [Abstract] [Full Text] [Related]
14. Commentary on: smarcb1 as a novel diagnostic and prognostic biomarker for osteosarcoma.
Sergi CM
Biosci Rep; 2022 Jun; 42(6):. PubMed ID: 35583077
[TBL] [Abstract] [Full Text] [Related]
15. Extraskeletal Mesenchymal Chondrosarcoma of Central Nervous System - A Rare but Aggressive Tumor: Analysis of Five Cases.
Chatterjee D; Radotra BD; Madan R; Gupta SK
Neurol India; 2022; 70(1):285-288. PubMed ID: 35263897
[TBL] [Abstract] [Full Text] [Related]
16. Oral involvement of sinonasal undifferentiated carcinoma: A case report and immunohistochemical study of a challenging case.
Gonçalves JM; Scarini JF; Gondak R; Altemani A; Mariano FV
Oral Oncol; 2022 Mar; 126():105779. PubMed ID: 35183913
[TBL] [Abstract] [Full Text] [Related]
17. Poorly Differentiated Chordoma of the Clivus With Loss of smarcb1 Expression in a Pediatric Patient: A Case Report.
Yasue S; Ozeki M; Endo S; Kanayama T; Suzui N; Nakamura S; Kishimoto K; Kosaka Y; Miyazaki T; Demizu Y; Soejima T; Kawamura A; Ohnishi H
J Pediatr Hematol Oncol; 2022 Nov; 44(8):465-470. PubMed ID: 35091519
[TBL] [Abstract] [Full Text] [Related]
18. smarcb1 expression is a novel diagnostic and prognostic biomarker for osteosarcoma.
Guo T; Wei R; Dean DC; Hornicek FJ; Duan Z
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34984436
[TBL] [Abstract] [Full Text] [Related]
19. Emerging concepts in sinonasal tumor research.
Lopez DC; Wadley AE; London NR
Curr Opin Otolaryngol Head Neck Surg; 2022 Feb; 30(1):33-39. PubMed ID: 34958321
[TBL] [Abstract] [Full Text] [Related]
20. Evaluating the effects of duloxetine on prophylaxis of oxaliplatin-induced peripheral neuropathy in patients with gastrointestinal cancer: A randomized double-blind placebo controlled clinical trial.
Rokhsareh S; Haghighi S; Tavakoli-Ardakani M
J Oncol Pharm Pract; 2023 Jan; 29(1):60-65. PubMed ID: 34738855
[TBL] [Abstract] [Full Text] [Related]
[Next]